行情

IRIX

IRIX

IRIDEX
NASDAQ

实时行情|Nasdaq Last Sale

2.020
0.000
0.00%
已收盘, 16:00 11/12 EST
开盘
1.975
昨收
2.020
最高
2.020
最低
1.975
成交量
6.18万
成交额
--
52周最高
5.69
52周最低
1.500
市值
2,783.91万
市盈率(TTM)
-2.3256
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

IRIX 新闻

  • IRIDEX Corp (IRIX) CEO David Bruce on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.4天前
  • Edited Transcript of IRIX earnings conference call or presentation 7-Nov-19 10:00pm GMT
  • Thomson Reuters StreetEvents.4天前
  • IRIDEX EPS beats by $0.04, beats on revenue
  • seekingalpha.5天前
  • Iridex Reiterates FY19 Sales Guidance $41M-$44M Vs. $42.48M Est.
  • Benzinga.5天前

更多

所属板块

先进医疗设备和技术
+0.97%
医疗设备和用品
+0.81%

热门股票

名称
价格
涨跌幅

IRIX 简况

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). In addition, the Company's ophthalmology products are often used in vitrectomy procedures (used to treat proliferative diabetic retinopathy, macular holes, retinal tears and detachments), which are generally performed in the operating room and require a consumable single use intraocular laser probe (EndoProbe) to deliver light to the back of the eye together with other instrumentation.
展开

Webull提供IRIDEX Corporation的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。